Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrickability Group Regulatory News (BRCK)

Share Price Information for Brickability Group (BRCK)

Share Price is delayed by 15 minutes
Get Live Data
48.65    -1.10 (-2.21%)
Bid:
48.20
Ask:
48.65
Spread: 0.45 (0.934%)
Market Cap: £156.72m
BRCK Live PriceLast checked at - London Stock Exchange

Intraday Brickability Group Share Chart

Form 8.3 - BRCK Group plc

1 Apr 2026 10:32

RNS Number : 0722Z
Hanover Investors Management LLP
01 April 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Hanover Investors Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Hanover Catalyst Fund

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BRCK Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

31st March 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

11,501,500.00

3.57%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

11,501,500.00

3.57%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

1st April 2026

Contact name:

Brian Cullen

Telephone number*:

+44 (0) 20 7766 8400

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETKFLBBQZLXBBB
Date   Source Headline
9th May 202410:11 amRNSDirector/PDMR Shareholding
1st May 20243:31 pmRNSTotal Voting Rights
26th Apr 20247:00 amRNSPre-Close Trading Update
15th Apr 20247:00 amRNSConfirmation of CEO start date
2nd Apr 202411:30 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSChange of Adviser
12th Mar 20246:10 pmRNSAIM Rule 17 Disclosure
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 202411:25 amRNSDirector/PDMR Shareholding
5th Mar 20243:21 pmRNSHolding(s) in Company
4th Mar 20244:32 pmRNSHolding(s) in Company
1st Mar 20248:27 amRNSTotal Voting Rights
28th Feb 20249:45 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSTrading Update
26th Feb 20245:42 pmRNSDirector/PDMR Shareholding
20th Feb 20243:50 pmRNSHolding(s) in Company
8th Feb 20242:11 pmRNSHolding(s) in Company
1st Feb 20245:11 pmRNSBlock listing six monthly returns
1st Feb 20245:08 pmRNSTotal Voting Rights
1st Feb 20245:03 pmRNSDirector/PDMR Shareholding
30th Jan 20245:03 pmRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 202410:12 amRNSGrant of Options
24th Jan 20245:35 pmRNSDirector/PDMR Shareholding
24th Jan 20243:39 pmRNSHolding(s) in Company
24th Jan 20243:36 pmRNSHolding(s) in Company
23rd Jan 202411:47 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSAcquisition of TSL Assets Limited
2nd Jan 20246:10 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for six months ended 30 Sept 2023
22nd Nov 20237:00 amRNSInvestor Presentation via Investor Meet Company
22nd Nov 20237:00 amRNSVesting of LTIP Awards and PDMR Shareholding
21st Nov 20237:00 amRNSNotice of Interim Results and Analyst Presentation
17th Nov 20237:00 amRNSBlock Admission
23rd Oct 20232:13 pmRNSChange of Nominated Adviser and Broker
20th Oct 20239:25 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSTrading Update & Acquisition
5th Sep 20238:30 amRNSAGM Statement
31st Aug 20235:19 pmRNSTotal Voting Rights
2nd Aug 20239:06 amRNSBlock listing Interim Review
25th Jul 202311:09 amRNS2023 Annual Report and Notice of AGM
21st Jul 20232:17 pmRNSHolding(s) in Company
17th Jul 20231:41 pmRNSInvestor Presentation via Investor Meet Company
17th Jul 20237:00 amRNSFinal results for the year ended 31 March 2023
10th Jul 20237:00 amRNSNotice of Results & Analyst Presentation
26th May 20237:00 amRNSChief Executive Officer Succession
26th Apr 20237:00 amRNSPre-Close Trading Update
14th Apr 20233:44 pmRNSHolding(s) in Company
4th Apr 20239:08 amRNSTotal Voting Rights
3rd Mar 20237:00 amRNSResignation of Independent Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.